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Abstract  Arthritis was induced in 9-week-old female Dark Agouti rats by 
injecting type II collagen.  Serum levels of the derivatives of reactive oxygen 
metabolites (dROMs), which are oxidative stress markers, and C-reactive 
protein (CRP) in arthritic rats that were exposed to a pressure of 1.25 
atmospheres absolute and an oxygen concentration of 36% for 3 weeks (arthritis 
+ HBO group) were compared to those of control rats (control group) and 
arthritic rats that were not exposed to hyperbaric oxygen (arthritis group).  The 
body weights of the arthritis and arthritis + HBO groups were lower than that of 
the control group, whereas no difference in the body weight was observed 
between the arthritis and arthritis + HBO groups.  The serum levels of dROMs 
and CRP in the arthritis group were higher than those in the control and arthritis 
+ HBO groups.  No difference in the serum level of CRP was observed between 
the control and arthritis + HBO groups.  These results indicate that the 
conditions of hyperbaric oxygen exposure used in this study are effective for 
reducing the levels of reactive oxygen species, which are overproduced during 
arthritis. 
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Highly reactive and toxic transient chemical species, referred to as 
reactive oxygen species (ROS), are overproduced by phagocytes during the 
development and progression of inflammatory processes and pathogenesis in a 
number of diseases [1].  The excessive production of ROS can damage cellular 
components such as nucleic acids, lipids, proteins, membranes, and matrix 
components.  In addition, ROS serve as important intracellular signaling and 
regulatory molecules that enhance the synovial inflammatory-proliferative 
response [2].  Oxygen metabolism plays an important role in the pathogenesis 
of many joint diseases.  The potential sources of ROS production are numerous 
in the case of joint diseases.  In degenerative joint diseases, proinflammatory 
factors such as cytokines and prostaglandins are released at sites of 
inflammation and destruction together with ROS [3].  The production of tumor 
necrosis factor (TNF)-α contributes to excessive ROS release and causes 
substantial reduction in the activity of antioxidant enzymes in inflammatory joints.  
Several other proinflammatory cytokines, including interleukin (IL)-1, IL-6, and 
IL-8, are produced by synovial cells; these cytokines recruit neutrophils into the 
synovial fluids and exert their effects by activating the intracellular signaling 
pathways [4].  C-reactive protein (CRP) is a marker of inflammation and 
destruction of tissues such as cartilage and bone.  The serum level of CRP 
correlates with the production of derivatives of reactive oxygen metabolites 
(dROMs), which are oxidative stress markers [5, 6]. 
An elevation in atmospheric pressure accompanied by an increase in 
oxygen concentration enhances the partial pressure of oxygen and increases 
the concentration of dissolved oxygen in the plasma.  We determined that a 
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pressure of 1.25 atmospheres absolute (ATA) and an oxygen concentration of 
36% are required for obtaining effective responses with regard to oxidative 
metabolism [7, 8].  Previous studies [9, 10] have reported low levels of partial 
pressure of oxygen in the synovial fluid of arthritic joints.  These joints are 
characterized by hypoxia, which is caused by increased oxygen demand and 
decreased blood flow [11–13].  Hypoxic conditions induce the production of 
proinflammatory cytokines and excessive ROS release in inflammatory joints.  
We hypothesized that increased pressure and enhanced delivery and uptake of 
oxygen induced by exposure to hyperbaric oxygen are effective in reducing 
arthritis-induced inflammation because exposure to hyperbaric oxygen may 
prevent and improve hypoxic conditions in inflammatory joints. 
In this study, we compared the serum levels of dROMs, TNF-α, IL-6, and 
CRP in arthritic rats that were exposed to hyperbaric oxygen to those of control 
rats and arthritic rats that were not exposed to hyperbaric oxygen.  We verified 
that the conditions of hyperbaric oxygen exposure used in this study are 
effective for decreasing the levels of ROS, which are overproduced during 
arthritis. 
 
Materials and methods 
All experimental procedures and animal care were conducted in 
accordance with the guidelines stated in the Guide for the Care and Use of 
Laboratory Animals issued by the Institutional Animal Experimentation 




Bovine type II collagen (CII) was dissolved in 0.1 M acetic acid at a 
concentration of 2 mg/ml by stirring overnight at 4°C.  Dissolved CII was frozen 
at a temperature of -70°C until use.  We immunized 9-week-old female Dark 
Agouti (DA) rats (n = 12), which are susceptible to induction of adjuvant arthritis, 
with an emulsion of 2 mg/ml of CII in incomplete Freund’s adjuvant (IFA).  The 
emulsions were prepared by homogenizing 1 part of dissolved CII into 1 part of 
IFA placed in an ice-water bath.  The rats were anesthetized by an 
intraperitoneal injection of sodium pentobarbital (50 mg/kg body weight); 
thereafter, 0.2 ml of the emulsion was intradermally injected into 3–5 other sites 
located on the back of each rat.  Following injection, half of these rats (arthritis 
+ HBO group; n = 6) were exposed to a pressure of 1.25 ATA (950 mmHg) and 
an oxygen concentration of 36%, automatically maintained by a 
computer-assisted system, for 3 weeks, while the other rats (arthritis group; n = 
6) were placed in a hyperbaric chamber under normal conditions (1 ATA (760 
mmHg) and 21% oxygen concentration); therefore, this group was not exposed 
to hyperbaric oxygen.  Nonimmunized DA rats (control group; n = 6) served as 
controls.  All rats were individually housed in same-sized cages in a room 
maintained under controlled 12-h light-dark cycles (lights switched off from 2000 
to 0800) at a temperature of 22 ± 2°C with a relative humidity of 45–65%.  Food 
and water were provided ad libitum to all groups.  The body weight of each rat 
was measured every week.  The pictures of the paws in all rats were taken 
when they were 12 weeks old.  The arthritis severity was determined by means 
of visual examination, on the basis of the number of instances of knuckle 
swelling (0 point, no sign; 1 point, 1 or 2 digits; 2 points, 3 digits; 3 points, 4 
digits; and 4 points, all digits), and the degree of arch edema (0 point, no sign; 1 
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point, light; 2 points, mild; 3 points, heavy; and 4 points, severe).  The arthritis 
score of each rat was calculated by determining the average of the points 
assigned to individual paws.  Therefore, the lowest arthritis score corresponded 
to 0 points, while the highest arthritis score corresponded to 8 points. 
 
Blood sampling and biochemical measurements 
Following 12 h of fasting, blood samples were collected from the 
abdominal aorta of the rats anesthetized by an intraperitoneal injection of sodium 
pentobarbital (50 mg/kg body weight).  The blood samples were centrifuged 
(6,000 g; 1 min) and evaluated photometrically.  We used a device capable of 
determining the levels of free radicals and antioxidant potentials (Free Radical 
Analytical System 4; Health & Diagnostics; Grosseto, Italy) to measure the 
serum level of dROMs [14].  The serum level of dROMs was used as an index 
to determine the level of oxidative stress induced by measuring the amount of 
organic hydroperoxide (ROOH) converted into radicals that oxidize 
N,N-diethyl-para-phenylenediamine.  The serum levels of TNF-α (R&D 
Systems, Inc.; MN, USA), IL-6 (R&D Systems, Inc.), and CRP (Helica 
Biosystems, Inc.; CA, USA) were measured by a routine laboratory method 
using the enzyme-linked immunosorbent assay (ELISA) kit. 
 
Statistical analysis 
Values are presented as mean and standard deviation.  One-way 
analysis of variance (ANOVA) was used to evaluate the differences among 
groups.  When the differences were found to be significant, further comparisons 
were made by performing post hoc tests.  A probability level of 0.05 was 
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No difference in the body weight was observed among the control, 
arthritis, and arthritis + HBO groups at 9, 10, and 11 weeks of age (Figure 1).  In 
contrast, the body weights of the 12-week-old arthritis and arthritis + HBO 
groups were lower than that of the age-matched control group. 
 
 
Fig. 1 The body weights of control rats and arthritic rats that were and were not exposed 
to hyperbaric oxygen.  Data are presented as mean and standard deviation as 
determined from 6 animals.  HBO, hyperbaric oxygen exposure.  *P < 0.05 compared 
to age-matched control rats. 
 
Arthritis severity 
The rats in the control group were not arthritic (Fig. 2, A1–6).  In 
contrast, the rats in the arthritis (Fig. 2, B1–6) and arthritis + HBO (Fig. 2, C1–6) 
groups presented with knuckle swelling and/or arch edema.  No difference in 
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the arthritis score was observed between the arthritis (6.0 ± 2.3, n = 6) and 
arthritis + HBO (4.8 ± 1.6, n = 6) groups. 
 
 
Fig. 2 The hind-paws of control (A1–6) and arthritic rats that were (C1–6) and were not 
(B1–6) exposed to hyperbaric oxygen.  The scale bar on C6 indicates 1 cm. 
 
Serum level of dROMs 
The serum levels of dROMs in the arthritis and arthritis + HBO groups 
were higher than that in the control group (Figure 3A).  The serum level of 
dROMs in the arthritis + HBO group was lower than that in the arthritis group. 
 
 
Fig. 3 The serum levels of derivatives of reactive oxygen metabolites (A) and C-reactive 
proteins (B) in control rats and arthritic rats that were and were not exposed to 
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hyperbaric oxygen.  Data are presented as mean and standard deviation as 
determined from 6 animals.  dROMs, derivatives of reactive oxygen metabolites; 
U.CARR, unit of Carratelli, which is a conventional unit named after an Italian biologist 
who developed a scale based on the observations from a group of more than 5,000 
non-smoking healthy subjects with age ranging from 14 to 80 years (1 U.CARR = 0.08 
mg of hydroperoxide/100 ml hydrogen peroxide); CRP, C-reactive protein; HBO, 
hyperbaric oxygen exposure.  *P < 0.05 compared to control rats; +P < 0.05 compared 
to control and arthritis + HBO rats. 
 
Serum levels of TNF-α, IL-6, and CRP 
Neither TNF-α nor IL-6 was detected in the rats, irrespective of whether 
they were arthritic and were exposed to hyperbaric oxygen.  The serum level of 
CRP in the arthritis group was higher than those in the control and arthritis + 
HBO groups (Figure 3B).  No difference in the serum level of CRP was 
observed between the control and arthritis + HBO groups. 
 
Discussion 
Type II collagen-induced arthritis 
Mice and rats with type II collagen-induced arthritis are widely used as 
experimental animal models of inflammatory polyarthritis with clinical and 
pathological features similar to those of rheumatism [15, 16].  The DA rats are 
susceptible to induction of adjuvant arthritis.  Arthritis is observed in 74% and 
100% DA rats at 2 weeks and 3 weeks after immunization, respectively (SLC 
Inc.; Tokyo, Japan).  The body weights of DA rats are observed to gradually 
decrease following immunization; the body weights are the lowest at 3 weeks 
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after immunization and subsequently recover to the control level (SLC Inc.).  In 
this study, we examined certain parameters of DA rats at 3 weeks after 
immunization because all immunized rats demonstrated high severity of arthritis, 
including the signs of knuckle swelling and/or arch edema (Fig. 2, B1–6).  
These arthritic rats may undergo further changes leading to cartilage and bone 
destruction when studied for a prolonged period; similar results were observed in 
a previous study using mice with type II collagen-induced arthritis [17]. 
 
Serum level of dROMs in arthritic rats 
Oxidative stress is the condition in which the production of oxidants 
exceeds the capacity to neutralize them.  Several factors could be involved in 
the generation of oxidative stress in inflammatory joints [18, 19].  ROS are 
produced during many metabolic processes, including mitochondrial respiration 
and enzyme activities.  ROS concentrations are regulated by maintaining the 
balance between their production and elimination by antioxidants.  An 
appropriate balance is crucial for normal cell and tissue function.  In contrast, 
the excessive production of ROS damages cellular components, including 
nucleic acids, lipids, proteins, membranes, and constituents of the extracellular 
matrix such as proteoglycans and collagens [2].  Previous studies [20, 21] have 
reported that excessive production of ROS causes an accelerated damage to 
joint cartilage and osteoclast activation.  We observed that the serum levels of 
dROMs, which serve as a marker of oxidative stress, were higher in arthritic rats 
than in control ones (Fig. 3A); this finding suggests that arthritis induces an 
excessive production of ROS. 
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Serum levels of TNF-α, IL-6, and CRP in arthritic rats 
Several proinflammatory cytokines (TNF-α, IL-1, IL-6, and IL-8) are 
produced by synovial cells and recruit neutrophils to the synovial fluids in arthritic 
rats.  However, we detected neither TNF-α nor IL-6 in the DA rats with arthritis.  
Previous studies [22, 23] have reported increased levels of TNF-α and IL-1β in 
Wistar or Lewis rats with type II collagen-induced arthritis.  We were unable to 
elucidate the reason underlying the inability to detect cytokines in arthritic DA 
rats. 
We observed increased serum levels of CRP in arthritic rats (Fig. 3B).  
Previous studies [24, 25] have reported that the serum level of CRP correlated 
with that of proinflammatory cytokines such as IL-6.  Increased serum levels of 
CRP are observed in inflammatory diseases [26].  Therefore, the increased 
serum levels of CRP reflect the arthritis severity, including signs of knuckle 
swelling and/or arch edema (Fig. 2, B1–6). 
 
Major drugs for arthritis 
It is widely accepted that reduction of oxidative stress by superoxide 
dismutase (SOD) affects the course of inflammation.  Several studies [27–30] 
have focused on synthetic low-molecular weight compounds that mimic the 
effects of SOD.  Among the various families of SOD mimetics, the most 
promising are nitroxides (tempol) and Mn (II) pentaazamacrocyclic ligand 
(M40403).  Tempol diminishes hydroxyl radical production and decreases the 
cytotoxic effects of hydrogen peroxide and peroxynitrite [27].  Furthermore, it 
decreases inflammation and tissue damage in rats with type II collagen-induced 
arthritis.  M40403 decreases the release of proinflammatory cytokines such as 
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TNF-α, probably by inhibiting the expression of the transcription factor, nuclear 
factor (NF)-κB [28].  The beneficial effects of M40403 have been reported in 
rats with collagen-induced arthritis [29, 30]. 
Treatment with 3,7,11,15-tetramethyl-2-hexadecene-1-ol (phytol) 
increases oxidative burst in vivo, decreases the autoimmune response, and 
ameliorates both the acute and chronic phase of arthritis in rats [31].  
Furthermore, treatment with alpha-lipoic acid (LA), which is a co-factor for 
mitochondrial α-keto dehydrogenase complexes and which participates in S-O 
transfer reactions, suppresses the development of collagen-induced arthritis in 
mice.  A previous study [32] reported that the amelioration of joint diseases by 
LA treatment was associated with reduction in oxidative stress, as well as with 
the inhibition of inflammatory cytokine activation and NF-κB DNA binding activity.  
Furthermore, LA-induced decreased intracellular ROS in lymphocytes obtained 
from the inguinal lymph nodes of arthritic mice and prevented bone destruction 
in vivo and osteoclastogenesis in vitro. 
 
Effects of exposure to hyperbaric oxygen 
Hyperbaric oxygen therapy leads to new vasoconstriction and 
hyperoxygenation, making it an effective treatment option for various clinical 
disorders [33–35].  This treatment involves administration of 100% oxygen 
concentration at a pressure greater than atmospheric pressure at sea level, 
usually equivalent to 2–3 ATA.  However, a standard procedure of hyperbaric 
oxygen therapy is known to cause excessive production of ROS in several 
tissues and organs [33, 34], suggesting that oxidative stress, which is induced by 
hyperbaric oxygen therapy, accelerates the tissue damage. 
 13
We determined that a pressure of 1.25 ATA and an oxygen concentration 
of 36% are required for obtaining effective responses with regard to oxidative 
metabolism [7, 8].  In this study, we exposed the rats to moderate atmospheric 
pressure and oxygen concentration as compared to those exposed to classical 
hyperbaric oxygen therapy with 100% oxygen concentration at 2 ATA; we 
observed that these conditions of hyperbaric oxygen exposure inhibit the 
excessive production of ROS.  Furthermore, these conditions of hyperbaric 
oxygen exposure are more cost-effective and safe; i.e. treatment at these 
conditions is not associated with the risk of accidents such as eardrum split.  
We observed that an excessive production of ROS in spontaneously 
hypertensive rats was inhibited by exposure to hyperbaric oxygen with 36% 
oxygen concentration at 1.25 ATA [36]. 
Intraarticular pressure is high in inflammatory joints because of 
decreased compliance of the joint wall, which is attributable to synovial 
membrane swelling and capsule fibrosis [37].  Other factors contributing to 
increased intraarticular pressure include movement and accumulation of 
synovial fluids in chronically involved joints [10].  Together with the reduced 
capillary density, this elevated pressure could decrease the rate of capillary 
blood flow and induce lowering of oxygen tension in synovial fluids and repetitive 
ischemia-reperfusion injury in the inflammatory joint [11–13].  This suggests 
that arthritic joints are characterized by hypoxia, which is caused by increased 
oxygen demand and decreased blood flow induced by increased intraarticular 
pressure.  These observations show that a potential therapeutic approach for 
treating arthritis would be to enhance the partial pressure of oxygen and 
increase the levels of dissolved oxygen for the elimination of ROS.  An increase 
 14
in atmospheric pressure and oxygen concentration enhances the partial 
pressure of oxygen; this increases the oxygen tension in the affected tissues and 
the concentration of dissolved oxygen in the plasma, thus enhancing the activity 
of oxidative enzymes in the mitochondria and, consequently, the rate of oxidative 
metabolism in cells and tissues.  Previously, we reported that the beneficial 
effects of hyperbaric oxygen exposure with 36% oxygen concentration at 1.25 
ATA were associated with an increased oxidative enzyme activity in skeletal 
muscle fibers and spinal motoneurons in rats [7, 8].  In addition, the possible 
beneficial effects of exposure to hyperbaric oxygen have been reported; the 
increase in blood glucose level, which is related to growth, of type 2 diabetic rats 
has been reported to be inhibited by exposure to hyperbaric oxygen [38–40].  
We observed that the levels of dROMs decreased in arthritic rats following 
exposure to hyperbaric oxygen (Fig. 3A); this indicated that the conditions of 
hyperbaric oxygen exposure used in this study are effective for decreasing the 
activity of ROS, which are overproduced in arthritic rats.  However, further 
studies are warranted to elucidate whether these effects of exposure to 
hyperbaric oxygen persist over prolonged periods.  In addition, clinical trials 
must be performed to evaluate the efficacy of exposure to hyperbaric oxygen for 
the treatment of arthritic patients. 
The arthritis scores did not differ between the arthritic rats that were and 
were not exposed to hyperbaric oxygen (Fig. 2).  This result indicates that the 
effects of exposure to hyperbaric oxygen on the dROM and CRP levels (Fig. 3) 
did not correspond with those on the morphological profiles of individual paws in 
arthritic rats.  Morphological effects of exposure to hyperbaric oxygen on rats 
may be observed if they were treated for a prolonged period; in this study, we 
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sacrificed the rats only 3 weeks after immunization.  Further studies are 
required to clarify time-dependent effects of exposure to hyperbaric oxygen on 
the morphological profiles of paws in arthritic rats. 
 
Conclusion 
A minor but significant decrease was induced in the serum levels of 
dROMs and CRP in arthritic rats after exposure to hyperbaric oxygen.  We 
conclude that the conditions of hyperbaric oxygen exposure used in this study 
are effective to decrease the activity of ROS, which are overproduced at an early 
stage of arthritis. 
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